Boothwyn Pharmacy LLC recalls Semaglutide
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Subpotent Drug
- Products
-
- Semaglutide
- Company
- Boothwyn Pharmacy LLC
- Where it was sold
-
U.S. Nationwide
Nationwide
- Units affected
- 648 vials
- About this recall
- Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy